News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
722,364 Results
Type
Article (46861)
Company Profile (295)
Press Release (675208)
Multimedia
Podcasts (68)
Webinars (12)
Section
Business (209288)
Career Advice (2190)
Deals (36021)
Drug Delivery (114)
Drug Development (82367)
Employer Resources (191)
FDA (16368)
Job Trends (15258)
News (352694)
Policy (33264)
Tag
Academia (2743)
Academic (2)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (51009)
ALS (99)
Alzheimer's disease (1430)
Antibody-drug conjugate (ADC) (139)
Approvals (16360)
Artificial intelligence (288)
Autoimmune disease (23)
Automation (17)
Bankruptcy (366)
Best Places to Work (11826)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (201)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (295)
Cancer (2354)
Cardiovascular disease (185)
Career advice (1838)
Career pathing (33)
CAR-T (165)
Cell therapy (457)
Cervical cancer (21)
Clinical research (66827)
Collaboration (888)
Company closure (2)
Compensation (570)
Complete response letters (21)
COVID-19 (2670)
CRISPR (43)
C-suite (259)
Cystic fibrosis (103)
Data (2344)
Decentralized trials (2)
Denatured (32)
Depression (45)
Diabetes (277)
Diagnostics (6533)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (123)
Drug pricing (112)
Drug shortages (26)
Duchenne muscular dystrophy (99)
Earnings (87931)
Editorial (42)
Employer branding (25)
Employer resources (161)
Events (116210)
Executive appointments (761)
FDA (17760)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (798)
Gene editing (114)
Generative AI (23)
Gene therapy (331)
GLP-1 (768)
Government (4584)
Grass and pollen (4)
Guidances (160)
Healthcare (19203)
Huntington's disease (26)
IgA nephropathy (30)
Immunology and inflammation (132)
Indications (29)
Infectious disease (2818)
Inflammatory bowel disease (148)
Inflation Reduction Act (10)
Influenza (52)
Intellectual property (100)
Interviews (346)
IPO (16737)
IRA (42)
Job creations (3845)
Job search strategy (1570)
Kidney cancer (10)
Labor market (46)
Layoffs (497)
Leadership (19)
Legal (8071)
Liver cancer (77)
Lung cancer (333)
Lymphoma (158)
Machine learning (9)
Management (62)
Manufacturing (335)
MASH (79)
Medical device (13540)
Medtech (13545)
Mergers & acquisitions (19859)
Metabolic disorders (731)
Multiple sclerosis (85)
NASH (22)
Neurodegenerative disease (99)
Neuropsychiatric disorders (27)
Neuroscience (2006)
NextGen: Class of 2025 (6717)
Non-profit (4650)
Now hiring (41)
Obesity (390)
Opinion (224)
Ovarian cancer (83)
Pain (94)
Pancreatic cancer (89)
Parkinson's disease (158)
Partnered (22)
Patents (248)
Patient recruitment (118)
Peanut (48)
People (59356)
Pharmaceutical (71)
Pharmacy benefit managers (19)
Phase I (20821)
Phase II (29420)
Phase III (21914)
Pipeline (1389)
Policy (152)
Postmarket research (2643)
Preclinical (9088)
Press Release (72)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (253)
Rare diseases (392)
Real estate (6228)
Recruiting (72)
Regulatory (22775)
Reports (56)
Research institute (2477)
Resumes & cover letters (374)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (76)
Series A (139)
Series B (91)
Service/supplier (14)
Sickle cell disease (55)
Special edition (17)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3783)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (50)
The Weekly (34)
Vaccines (728)
Venture capitalists (44)
Weight loss (256)
Women's health (38)
Worklife (18)
Date
Today (185)
Last 7 days (981)
Last 30 days (3213)
Last 365 days (33137)
2025 (12118)
2024 (35947)
2023 (40860)
2022 (51924)
2021 (56499)
2020 (54899)
2019 (47645)
2018 (35936)
2017 (33086)
2016 (32665)
2015 (38767)
2014 (32375)
2013 (27536)
2012 (29798)
2011 (30536)
2010 (29032)
Location
Africa (793)
Alabama (55)
Alaska (7)
Arizona (242)
Arkansas (14)
Asia (39569)
Australia (6511)
California (6490)
Canada (2075)
China (547)
Colorado (282)
Connecticut (282)
Delaware (159)
Europe (86087)
Florida (962)
Georgia (224)
Hawaii (1)
Idaho (58)
Illinois (564)
India (27)
Indiana (331)
Iowa (11)
Japan (173)
Kansas (108)
Kentucky (26)
Louisiana (12)
Maine (62)
Maryland (936)
Massachusetts (4853)
Michigan (243)
Minnesota (422)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (69)
New Hampshire (65)
New Jersey (1820)
New Mexico (30)
New York (1834)
North Carolina (1033)
North Dakota (9)
Northern California (2857)
Ohio (213)
Oklahoma (14)
Oregon (34)
Pennsylvania (1440)
Puerto Rico (13)
Rhode Island (33)
South America (1172)
South Carolina (26)
South Dakota (1)
Southern California (2432)
Tennessee (106)
Texas (966)
United States (24449)
Utah (193)
Virginia (153)
Washington D.C. (69)
Washington State (574)
West Virginia (3)
Wisconsin (67)
722,364 Results for "kodiak sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases
May 2, 2025
·
13 min read
Press Releases
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
March 28, 2025
·
24 min read
Press Releases
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy
March 11, 2025
·
13 min read
Press Releases
Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025
February 4, 2025
·
8 min read
Biotech Bay
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management will present at the following upcoming investor conferences.
May 29, 2024
·
4 min read
Press Releases
Kodiak Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
3 min read
Business
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended March 31, 2024.
May 15, 2024
·
16 min read
Press Releases
Kodiak Sciences to Participate in Upcoming Investor Conferences
November 11, 2024
·
3 min read
Biotech Bay
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak’s Antibody Biopolymer Conjugate (ABC) Platform
Kodiak Sciences Inc. announced that nine scientific presentations on its clinical and research pipeline programs will be made at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting, being held from May 5 – 9 in Seattle, Washington.
May 2, 2024
·
14 min read
Press Releases
Kodiak Sciences to Present at Innovate Retina 2024
October 15, 2024
·
3 min read
1 of 72,237
Next
